We wish you a truly happy holiday season, and we look forward to seeing you again in the new year. 2020 Highlights SenzaGen received GLP approval We can now offer GLP-compliant test services using the GARD™platform. Read more GARD™skin Dose-Response This newly released assay provides quantitative potency information related to skin sensitization. Learn more […]
Our CEO Axel Sjöblad gave an update on our commercial progress at Redeye Life Science Day last week. Watch the replay here:
Here is an interview with Principal Scientist Gretchen Ritacco, MS, explaining why RIFM has focused some of its research on the potential for light to activate fragrance materials resulting in reactions in the body’s largest organ, the skin. Since June 2020, SenzaGen and the Research Institute for Fragrance Materials (RIFM) are collaborating to investigate in […]
Safer Medical Devices – in vitro skin sensitization testing with human relevance and high accuracy By Rose-Marie Jenvert, PhD, and Joshua Schmidt, PhD, SenzaGen Watch by clicking the image below.
Toxicological Sciences, kfaa068, https://doi.org/10.1093/toxsci/kfaa068 Robin Gradin, Angelica Johansson, Andy Forreryd, Emil Aaltonen, Anders Jerre, Olivia Larne, Ulrika Mattson, Henrik Johansson Abstract Proactive identification and characterization of hazards attributable to chemicals are central aspects of risk assessments. Current legislations and trends in predictive toxicology advocate a transition from in vivo methods to non-animal alternatives. For skin sensitization assessment, […]
Thanks to all who attending yesterday’s GARDskin Dose-Response webinar. If you missed it, here’s a link to the recording.
Comments to the 2019 closing and 2020 update by CEO Axel Sjöblad.
The 2019 Annual Report in English is available. If you want to download it click here. To order a printed version, click here.
SenzaGen has received questions from customers and partners about how COVID-19 has affected our daily operations. We continue to monitor the development of the COVID-19 epidemic closely and recognize that this situation represents an unprecedented challenge to the daily lives of our communities across the globe. To date, we continue to offer our full range […]
